Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), bought 2,000 shares at $2.18 ($4K) on 2009-09-11, disclosed to the SEC on 2009-09-15.
Open-market purchase of $4k AVNR by Senior VP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |